ATC code A05: Difference between revisions
Jump to navigation
Jump to search
imported>Whywhenwhohow 2025 additions |
imported>Whywhenwhohow anchors, 2026 updates |
||
| Line 1: | Line 1: | ||
{{ATC codes lead|A|05|Bile and liver therapy|vet=add}} | {{ATC codes lead|A|05|Bile and liver therapy|vet=add}} | ||
== | ==<span class="anchor" id="A05A"></span>A05A Bile therapy== | ||
=== | ===<span class="anchor" id="A05AA"></span>A05AA Bile acids and derivatives=== | ||
:A05AA01 [[Chenodeoxycholic acid]] | :A05AA01 [[Chenodeoxycholic acid]] | ||
:A05AA02 [[Ursodeoxycholic acid]] | :A05AA02 [[Ursodeoxycholic acid]] | ||
| Line 9: | Line 9: | ||
:A05AA04 [[Obeticholic acid]] | :A05AA04 [[Obeticholic acid]] | ||
:A05AA05 [[Ursodoxicoltaurine]] | :A05AA05 [[Ursodoxicoltaurine]] | ||
:A05AA06 [[Norucholic acid]] | |||
=== | ===<span class="anchor" id="A05AB"></span>A05AB Preparations for biliary tract therapy=== | ||
:A05AB01 [[Nicotinyl methylamide]] | :A05AB01 [[Nicotinyl methylamide]] | ||
=== | ===<span class="anchor" id="A05AX"></span>A05AX Other drugs for bile therapy=== | ||
:A05AX01 [[Piprozolin]] | :A05AX01 [[Piprozolin]] | ||
:A05AX02 [[Hymecromone]] | :A05AX02 [[Hymecromone]] | ||
| Line 21: | Line 22: | ||
:A05AX06 [[Elafibranor]] | :A05AX06 [[Elafibranor]] | ||
:A05AX07 [[Seladelpar]] | :A05AX07 [[Seladelpar]] | ||
:A05AX08 [[Linerixibat]] | |||
:QA05AX90 [[Menbutone]] | :QA05AX90 [[Menbutone]] | ||
== | ==<span class="anchor" id="A05B"></span>A05B Liver therapy, lipotropics== | ||
=== | ===<span class="anchor" id="A05BA"></span>A05BA Liver therapy=== | ||
:A05BA01 [[Arginine glutamate]] | :A05BA01 [[Arginine glutamate]] | ||
:A05BA03 [[Silymarin]] | :A05BA03 [[Silymarin]] | ||
| Line 35: | Line 37: | ||
:A05BA09 [[Metadoxine]] | :A05BA09 [[Metadoxine]] | ||
:A05BA10 [[Phospholipid]]s | :A05BA10 [[Phospholipid]]s | ||
:A05BA11 [[Resmetirom]] | |||
:QA05BA90 [[Methionine]] | :QA05BA90 [[Methionine]] | ||
== | ==<span class="anchor" id="A05C"></span>A05C Drugs for bile therapy and lipotropics in combination== | ||
:''Empty group'' | :''Empty group'' | ||
Latest revision as of 06:58, 23 December 2025
A05A Bile therapy
A05AA Bile acids and derivatives
- A05AA01 Chenodeoxycholic acid
- A05AA02 Ursodeoxycholic acid
- A05AA03 Cholic acid
- A05AA04 Obeticholic acid
- A05AA05 Ursodoxicoltaurine
- A05AA06 Norucholic acid
A05AB Preparations for biliary tract therapy
- A05AB01 Nicotinyl methylamide
A05AX Other drugs for bile therapy
- A05AX01 Piprozolin
- A05AX02 Hymecromone
- A05AX03 Cyclobutyrol
- A05AX04 Maralixibat chloride
- A05AX05 Odevixibat
- A05AX06 Elafibranor
- A05AX07 Seladelpar
- A05AX08 Linerixibat
- QA05AX90 Menbutone
A05B Liver therapy, lipotropics
A05BA Liver therapy
- A05BA01 Arginine glutamate
- A05BA03 Silymarin
- A05BA04 Citiolone
- A05BA05 Epomediol
- A05BA06 Ornithine oxoglutarate
- A05BA07 Tidiacic arginine
- A05BA08 Glycyrrhizic acid (glycyrrhizin)
- A05BA09 Metadoxine
- A05BA10 Phospholipids
- A05BA11 Resmetirom
- QA05BA90 Methionine
A05C Drugs for bile therapy and lipotropics in combination
- Empty group
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".